HomeCompareARSUF vs ORCC

ARSUF vs ORCC: Dividend Comparison 2026

ARSUF yields 1.45% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARSUF wins by $17.18M in total portfolio value· pulled ahead in Year 2
10 years
ARSUF
ARSUF
● Live price
1.45%
Share price
$27.00
Annual div
$0.39
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17.20M
Annual income
$15,185,781.50
Full ARSUF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ARSUF vs ORCC

📍 ARSUF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARSUFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARSUF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARSUF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARSUF
Annual income on $10K today (after 15% tax)
$123.09/yr
After 10yr DRIP, annual income (after tax)
$12,907,914.28/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ARSUF beats the other by $12,907,913.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARSUF + ORCC for your $10,000?

ARSUF: 50%ORCC: 50%
100% ORCC50/50100% ARSUF
Portfolio after 10yr
$8.61M
Annual income
$7,592,891.27/yr
Blended yield
88.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ARSUF
No analyst data
Altman Z
3.9
Piotroski
7/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARSUF buys
0
ORCC buys
0
No recent congressional trades found for ARSUF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARSUFORCC
Forward yield1.45%9.79%
Annual dividend / share$0.39$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%-50%
Portfolio after 10y$17.20M$21.4K
Annual income after 10y$15,185,781.50$1.04
Total dividends collected$17.02M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ARSUF vs ORCC ($10,000, DRIP)

YearARSUF PortfolioARSUF Income/yrORCC PortfolioORCC Income/yrGap
1$10,990$289.63$11,190$489.61$200.00ORCC
2← crossover$12,354$594.94$12,229$256.01+$125.00ARSUF
3$14,469$1,250.08$13,216$130.74+$1.3KARSUF
4$18,218$2,736.60$14,207$66.02+$4.0KARSUF
5$25,934$6,440.67$15,234$33.17+$10.7KARSUF
6$44,887$17,137.37$16,317$16.62+$28.6KARSUF
7$103,471$55,441.98$17,468$8.32+$86.0KARSUF
8$349,596$238,882.57$18,695$4.16+$330.9KARSUF
9$1,882,687$1,508,619.21$20,006$2.08+$1.86MARSUF
10$17,200,257$15,185,781.50$21,407$1.04+$17.18MARSUF

ARSUF vs ORCC: Complete Analysis 2026

ARSUFStock

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Full ARSUF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ARSUF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARSUF vs SCHDARSUF vs JEPIARSUF vs OARSUF vs KOARSUF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.